HRA Pharma, Aska Pharmaceutical sales and marketing update

HRA Pharma granted Aska exclusive rights to develop and commercialize ulipristal acetate in Japan. HRA Pharma already markets the selective progesterone receptor modulator (SPRM), which is approved a...